Emergent BioSolutions Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Emergent BioSolutions Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Emergent BioSolutions Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Emergent BioSolutions Inc. is EBS:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Emergent BioSolutions Inc. has its primary listing on New York Stock Exchange. You can trade Emergent BioSolutions Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Emergent BioSolutions Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Emergent BioSolutions Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Emergent BioSolutions Inc..